Module 5

Getting your science to patients and customers

DATE: 11 February 2021 (16:00-18:00 GMT)

This course module will cover the following topics and provide participants with some additional further reading and information sources to look at, both before and after the session.

  • How do you develop your understanding of your market landscape – customers and competitors?
  • When and how you should start to engage with business to business or business to healthcare customers and how to prepare.
  • The importance of compelling vision and mission statements and how to craft them
  • What are the specific challenges of getting science to patients or into a healthcare system?
  • Stakeholders within healthcare systems or businesses that will influence your success – who are they and why do they matter?
  • Develop a roadmap from science to patients or customers that aligns market, technical and clinical readiness.

Louise Jopling, Commercial Director, Eastern Academic Health Science Network (EAHSN)

Louise joined Eastern AHSN as Commercial Director in February 2019, focussing on developing partnerships with industry to accelerate the uptake and adoption of health innovations to support NHS needs within the Eastern region. Louise has successfully worked across the spectrum of therapeutics research & development and commercialisation, including product launch and life-cycle management and, having gained this experience within academia, biotech, medium and large pharma, provides expertise from many different perspectives.

David Atkins, CEO, Congenica
David Atkins, CEO, Congenica, Ltd.

Accomplished global healthcare leader with strong emerging markets experience in a broad range of medical device sectors and specialty clinical services. Expertise includes clinical and molecular diagnostics, anatomic pathology, wound management, minimally invasive and general surgery,orthopaedics, sterilisation, anaesthetics and cellular diagnostics. Business leadership Internationally in US, Canada, EU, Emerging Markets (MiddleEast, Africa, Asia, Latin America). Start-up ventures, turnaround, and high-growth enterprise expertise. Broad functional expertise in sales and marketing, R&D pipeline, product development, QRC, and operations and business development.

Emmanuelle Astoul, head of Licensing, TranSINE Therapeutics
Emmanuelle Astoul, Head of Licensing, TranSINE Therapeutics

Formerly, a Senior Business Development Manager within the Technology Translation Office at the Wellcome Sanger Institute, Emmanuelle is passionate about encouraging scientists to develop the skills and knowledge necessary to help translate genomic science into innovative medicine. Whilst at Sanger, she founded a special training programme focused on commercialising genomics that covers everything from ethical use of data to regulatory and reimbursement strategies. Emmanuelle spent 9 years working at Sanger, her role encompassed commercialising Institute’s technologies, sharing its capability with biomedical industries in collaborative partnerships and maximising use in research and development of the genomic scale resources the Institute produces such as databases, bioinformatic pipelines, or scientific models.